Constantinos Zambirinis MD MRes
Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Fellow in Complex General Surgical Oncology
Join to View Full Profile
195 Little Albany streetDepartment of SurgeryNew Brunswick, NJ 08901
Dr. Zambirinis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I’m a general surgeon in my senior years of training, aiming in a specialization in surgical oncology, with special focus on diseases of the pancreas, liver, and biliary tract.
Parallel to my surgical training and clinical duties, I am heavily involved in translational cancer research, studying the role of different components of the immune system in pancreatic cancer development as well as the early steps of liver metastasis.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Surgery, 2018 - 2021
Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2016 - 2018
Harlem Hospital CenterResidency, Surgery, 2015 - 2016- Harlem Hospital CenterInternship, Surgery, 2014 - 2015
New York University School of MedicinePost-Doctoral Fellowship, 2011 - 2014
King's College LondonMRes, Translational Cancer Medicine, Distinction, 2009 - 2010
University of AthensClass of 2009, MD, Excellent (“Arista”)
Certifications & Licensure
NJ State Medical License 2021 - 2025
RI State Medical License 2018 - 2021
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 10 citationsMulti-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.Linda Bojmar, Constantinos P Zambirinis, Jonathan M Hernandez, Jayasree Chakraborty, Lee Shaashua
Nature Medicine. 2024-08-01 - 87 citationsTumour extracellular vesicles and particles induce liver metabolic dysfunction.Gang Wang, Jianlong Li, Linda Bojmar, Haiyan Chen, Zhong Li
Nature. 2023-06-01 - ASO Author Reflections: Predicting Pancreatic Cancer Liver Metastasis by Integrating Primary Tumor Clinicopathologic Features and Liver Radiomics.Constantinos P Zambirinis, William R Jarnagin
Annals of Surgical Oncology. 2022-08-01
Authored Content
- HIPEC: Evolution, Management, and Outcomes - Dr. Constantinos Zambirinis, MD [Brown Surgery Podcast]May 2021
Press Mentions
Microscopic Changes in the Liver Can Be Used to Predict Pancreatic Cancer SpreadJuly 5th, 2024
Grant Support
- Development of Novel Imaging and Laboratory Biomarkers to Monitor the Liver Pre-metastatic Niche and Guide TreatmentMSKCC Metastasis & Tumor Ecosystems Center2016–2018
- The role of bacteria in modulating pancreatic tumorigenesisNational Pancreas Foundation2013–2014
Professional Memberships
- Member
- Member
- Member
- Member
- Society of Surgical Oncology - SSOMember
- American Hepato-Pancreato-Biliary Association - AHPBAMember
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
